{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:36:05Z","timestamp":1793824565762,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.03.085","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T08:45:42Z","timestamp":1618303542000},"page":"2643-2651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-2259","authenticated-orcid":false,"given":"Roman","family":"Prymula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Povey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Brzostek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Cabrnochova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Chlibek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Czajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giedra","family":"Leviniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-0970","authenticated-orcid":false,"given":"Mihai","family":"Neamtu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Pazdiora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Plesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Ruzkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stefkovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytautas","family":"Usonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Verdanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Ahsan","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9544","key":"10.1016\/j.vaccine.2021.03.085_b0005","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.03.085_b0010","unstructured":"European Centre for Disease Prevention and Control. Vaccination scheduler. http:\/\/vaccine-schedule.ecdc.europa.eu\/. [last accessed 10 April 2020]."},{"key":"10.1016\/j.vaccine.2021.03.085_b0015","doi-asserted-by":"crossref","unstructured":"Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, et al. Implementing universal varicella vaccination in Europe the path forward. Pediatr Infect Dis J. 2019;38:181\u20138. http:\/\/dx.doi.org\/10.1097\/inf.0000000000002233.","DOI":"10.1097\/INF.0000000000002233"},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.085_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2445-2","article-title":"Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization","volume":"17","author":"Riera Montes","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.085_b0025","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2021.03.085_b0030","doi-asserted-by":"crossref","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.085_b0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","article-title":"Varicella vaccination \u2013 the global experience","volume":"16","author":"Wutzler","year":"2017","journal-title":"Expert Rev Vacc"},{"issue":"4","key":"10.1016\/j.vaccine.2021.03.085_b0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14760584.2018.1433999","article-title":"Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccinationa meta-analysis","volume":"17","author":"Yin","year":"2018","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2021.03.085_b0045","doi-asserted-by":"crossref","unstructured":"Bonanni P, Gershon A, Gershon M, Kulcs\u00e1r A, Papaevangelou V, Rentier B, et al. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J. 2013;32:e305-13. http:\/\/dx.doi.org\/10.1097\/INF.0b013e31828b7def.","DOI":"10.1097\/INF.0b013e31828b7def"},{"key":"10.1016\/j.vaccine.2021.03.085_b0050","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2021.03.085_b0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety","volume":"94","author":"Ma","year":"2015","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"10.1016\/j.vaccine.2021.03.085_b0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","article-title":"Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix)","volume":"22","author":"Kreth","year":"2008","journal-title":"BioDrugs"},{"issue":"47","key":"10.1016\/j.vaccine.2021.03.085_b0065","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"issue":"9925","key":"10.1016\/j.vaccine.2021.03.085_b0070","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2021.03.085_b0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.vaccine.2017.11.081","article-title":"One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life","volume":"36","author":"Henry","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.03.085_b0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1473-3099(18)30716-3","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial","volume":"19","author":"Povey","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.03.085_b0085","series-title":"The pink book","article-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2002"},{"issue":"36","key":"10.1016\/j.vaccine.2021.03.085_b0090","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1016\/j.vaccine.2019.07.049","article-title":"Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: a 10-year follow-up","volume":"37","author":"Carryn","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.03.085_b0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Statist Soc Ser B"},{"key":"10.1016\/j.vaccine.2021.03.085_b0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"issue":"8","key":"10.1016\/j.vaccine.2021.03.085_b0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/14760584.2015.1057572","article-title":"Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials","volume":"14","author":"Leung","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2021.03.085_b0110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40264-015-0326-4","article-title":"Modelling hospitalisation ratios for febrile convulsions and severe varicella under combined measles, mumps, rubella, and varicella (MMRV-Priorix-Tetra\u2122) compared to separate MMR + V vaccination","volume":"38","author":"Bauchau","year":"2015","journal-title":"Drug Saf"},{"issue":"34","key":"10.1016\/j.vaccine.2021.03.085_b0115","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.vaccine.2021.03.085_b0120","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2021.03.085_b0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","article-title":"Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination","volume":"32","author":"Schink","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.03.085_b0130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamapediatrics.2017.1965","article-title":"Evaluation of combination measles-mumps-rubella-varicella vaccine introduction in Australia","volume":"171","author":"Macartney","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2021.03.085_b0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.rpped.2015.12.006","article-title":"The impact of varicella vaccination on varicella-related hospitalization rates: global data review","volume":"34","author":"Hirose","year":"2016","journal-title":"Rev Paul Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2021.03.085_b0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.03.085_b0145","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12889-016-3738-x","article-title":"Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy","volume":"16","author":"Holl","year":"2016","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:55:02Z","timestamp":1759402502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X21004011"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}